329 related articles for article (PubMed ID: 7737939)
1. Transfusion-transmitted cytomegalovirus infection.
Bowden RA
Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
[TBL] [Abstract][Full Text] [Related]
2. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
[TBL] [Abstract][Full Text] [Related]
3. [Leukocyte depletion and infection by cytomegalovirus].
Mazeron MC
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():31s-35s. PubMed ID: 10919221
[TBL] [Abstract][Full Text] [Related]
4. Posttransfusion cytomegalovirus infections.
Tegtmeier GE
Arch Pathol Lab Med; 1989 Mar; 113(3):236-45. PubMed ID: 2537614
[TBL] [Abstract][Full Text] [Related]
5. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
[TBL] [Abstract][Full Text] [Related]
6. CMV and blood transfusions.
Roback JD
Rev Med Virol; 2002; 12(4):211-9. PubMed ID: 12125013
[TBL] [Abstract][Full Text] [Related]
7. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
Smith D; Lu Q; Yuan S; Goldfinger D; Fernando LP; Ziman A
Vox Sang; 2010 Jan; 98(1):29-36. PubMed ID: 19695013
[TBL] [Abstract][Full Text] [Related]
8. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
[TBL] [Abstract][Full Text] [Related]
9. [Transmission cytomegalovirus infection by blood transfusions].
Mañez R
Sangre (Barc); 1993 Jun; 38(3):201-4. PubMed ID: 8211545
[No Abstract] [Full Text] [Related]
10. Cytomegalovirus infection.
Climent C; Vélez R; Capriles JA
Bol Asoc Med P R; 1992 Jan; 84(1):31-3. PubMed ID: 1323967
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H
Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in a neonatal intensive care unit. Subsequent morbidity and mortality of seropositive infants.
Griffin MP; O'Shea M; Brazy JE; Klein D; Koepke J; Malloy C; Wilfert CM
J Perinatol; 1990 Mar; 10(1):43-5. PubMed ID: 2156031
[TBL] [Abstract][Full Text] [Related]
15. Congenital cytomegalovirus infection as a preventable complication of maternal transfusion. A case report.
McGregor JA; Rubright G; Ogle JW
J Reprod Med; 1990 Jan; 35(1):61-4. PubMed ID: 2153814
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India.
Kothari A; Ramachandran VG; Gupta P; Singh B; Talwar V
J Health Popul Nutr; 2002 Dec; 20(4):348-51. PubMed ID: 12659416
[TBL] [Abstract][Full Text] [Related]
17. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
Ljungman P
Br J Haematol; 2004 Apr; 125(2):107-16. PubMed ID: 15059132
[No Abstract] [Full Text] [Related]
18. Cytomegalovirus infection in seronegative patients treated with prophylaxis: case-controlled study.
Moreno de la Higuera Díaz MA; Calvo Romero N; Sánchez-Fructuoso A; Conesa J; Marques Vidas M; Prats D; Barrientos Guzmán A
Transplant Proc; 2007 Sep; 39(7):2231-2. PubMed ID: 17889147
[TBL] [Abstract][Full Text] [Related]
19. Neonatal cytomegalovirus infections due to blood.
Adler SP
Crit Rev Clin Lab Sci; 1986; 23(1):1-14. PubMed ID: 3004810
[TBL] [Abstract][Full Text] [Related]
20. [Cytomegalovirus and blood transfusion].
Eggen BM
Tidsskr Nor Laegeforen; 1993 Jan; 113(1):22-4. PubMed ID: 8380944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
